Stockscreener 앱 받기
69.00
3.52%
2.39
전일 마감가:
$66.61
열려 있는:
$65.75
하루 거래량:
534.08K
Relative Volume:
0.98
시가총액:
$2.93B
수익:
$17.39M
순이익/손실:
$-135.89M
주가수익비율:
-14.87
EPS:
-4.64
순현금흐름:
$-123.00M
1주 성능:
+13.45%
1개월 성능:
+0.87%
6개월 성능:
+20.44%
1년 성능:
+44.13%
1일 변동 폭
$65.75
$69.56
1주일 범위
$60.88
$69.56
52주 변동 폭
$38.51
$85.25
Tarsus Pharmaceuticals Inc Stock (TARS) Company Profile
명칭
Tarsus Pharmaceuticals Inc
전화
(949) 409-9820
주소
15440 LAGUNA CANYON ROAD, IRVINE
Compare TARS vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TARS
Tarsus Pharmaceuticals Inc
|
68.93 | 2.83B | 17.39M | -135.89M | -123.00M | -4.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
485.79 | 121.15B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
788.49 | 82.43B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
835.73 | 52.25B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
330.60 | 44.59B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
366.93 | 40.07B | 4.98B | 69.60M | 525.67M | 0.5198 |
Tarsus Pharmaceuticals Inc Stock (TARS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-09 | 개시 | Barclays | Overweight |
| 2025-11-20 | 개시 | Mizuho | Outperform |
| 2025-06-02 | 재개 | Oppenheimer | Outperform |
| 2025-05-27 | 재개 | H.C. Wainwright | Buy |
| 2023-11-20 | 개시 | Goldman | Neutral |
| 2023-07-18 | 개시 | William Blair | Outperform |
| 2023-05-18 | 개시 | Guggenheim | Buy |
| 2022-08-01 | 개시 | Barclays | Overweight |
| 2021-12-21 | 개시 | H.C. Wainwright | Buy |
| 2021-11-23 | 개시 | Oppenheimer | Outperform |
| 2020-11-10 | 개시 | BofA Securities | Buy |
| 2020-11-10 | 개시 | Jefferies | Buy |
| 2020-11-10 | 개시 | Ladenburg Thalmann | Buy |
| 2020-11-10 | 개시 | Raymond James | Strong Buy |
모두보기
Tarsus Pharmaceuticals Inc 주식(TARS)의 최신 뉴스
Will Tarsus Pharmaceuticals Inc. stock recover after earnings2025 Technical Patterns & Daily Growth Stock Investment Tips - mfd.ru
Published on: 2026-02-21 16:01:43 - baoquankhu1.vn
What is the long term forecast for Tarsus Pharmaceuticals Inc. stockBull Run & Smart Swing Trading Alerts - mfd.ru
Earnings To Watch: Tarsus Pharmaceuticals Inc (TARS) Reports Q4 2025 Result - GuruFocus
Tarsus Pharmaceuticals Appoints David Pyott to its Board of Directors - VisionMonday.com
Does Adding Ophthalmology Veteran David Pyott to the Board Change The Bull Case For Tarsus (TARS)? - Yahoo Finance
A Look At Tarsus Pharmaceuticals (TARS) Valuation After Adding Former Allergan CEO David Pyott To Its Board - Yahoo Finance
Tarsus Pharmaceuticals Appoints Renowned Biopharmaceutical Leader - The National Law Review
Tarsus Pharmaceuticals Appoints Renowned Biopharmaceutical Leader and Former Allergan CEO, David Pyott, to its Board of Directors - BioSpace
Tarsus Pharmaceuticals (TARS) Welcomes Former Allergan CEO to Bo - GuruFocus
Tarsus Pharmaceuticals Adds Industry Veteran to Board - TipRanks
Former Allergan CEO David Pyott joins Tarsus Pharmaceuticals board - Investing.com
Ex-Allergan chief who grew sales to $7B joins Tarsus board - Stock Titan
Tarsus to Report Fourth Quarter and Full Year 2025 Financial Results on Monday, February 23, 2026 - The Manila Times
Tarsus Pharmaceuticals, Inc. (TARS) Expected to Beat Earnings Estimates: Can the Stock Move Higher? - Bitget
Tarsus Pharmaceuticals, Inc. (TARS) Stock Analysis: Eye-Catching 52% Upside Potential Sparks Investor Interest - DirectorsTalk Interviews
Tarsus Pharmaceuticals (TARS) Projected to Post Quarterly Earnings on Tuesday - MarketBeat
(TARS) Movement as an Input in Quant Signal Sets - Stock Traders Daily
TimesSquare Capital Management LLC Invests $15.90 Million in Tarsus Pharmaceuticals, Inc. $TARS - MarketBeat
Can Tarsus Pharmaceuticals Inc. benefit from deglobalization2025 Retail Activity & Weekly Top Gainers Trade List - mfd.ru
Tarsus Pharmaceuticals (NASDAQ:TARS) versus Monopar Therapeutics (NASDAQ:MNPR) Head to Head Comparison - Defense World
Will Tarsus Pharmaceuticals Inc. be affected by tariffsJuly 2025 Breakouts & Verified Momentum Watchlists - mfd.ru
Will Tarsus Pharmaceuticals Inc. benefit from rising consumer demandShort Setup & Capital Protection Trade Alerts - mfd.ru
Can Tarsus Pharmaceuticals Inc. maintain sales growthStop Loss & Weekly Breakout Opportunity Watchlist - mfd.ru
Can Tarsus Pharmaceuticals Inc. stock sustain free cash flow growthJuly 2025 Pullbacks & Accurate Buy Signal Alerts - mfd.ru
Why is Tarsus Pharmaceuticals Inc stock going down2025 Growth vs Value & Consistent Profit Trade Alerts - baoquankhu1.vn
Will Tarsus Pharmaceuticals Inc. stock recover faster than market2025 Trading Volume Trends & Long-Term Capital Growth Strategies - mfd.ru
Panic Selling: Is Tarsus Pharmaceuticals Inc still a buy after recent gainsJuly 2025 Levels & Reliable Intraday Trade Plans - baoquankhu1.vn
Federated Hermes Inc. Has $905,000 Stock Position in Tarsus Pharmaceuticals, Inc. $TARS - MarketBeat
Shareholders Should Be Pleased With Tarsus Pharmaceuticals, Inc.'s (NASDAQ:TARS) Price - simplywall.st
Liquidity Mapping Around (TARS) Price Events - Stock Traders Daily
Dow Update: Does Tarsus Pharmaceuticals Inc have declining or rising EPS2025 EndofYear Setup & Daily Profit Focused Screening - baoquankhu1.vn
Stocks to watch: Tarsus Pharmaceuticals sees RS rating rise to 81 - MSN
Lisanti Capital Growth LLC Has $2.56 Million Position in Tarsus Pharmaceuticals, Inc. $TARS - MarketBeat
Tarsus prices $125M stock offering - MSN
Does Tarsus Pharmaceuticals Inc have declining or rising EPSBuy Signal & Intraday High Probability Setup Alerts - baoquankhu1.vn
Will Tarsus Pharmaceuticals Inc. benefit from green energy policies2025 Key Highlights & High Win Rate Trade Alerts - mfd.ru
Investors Still Waiting For A Pull Back In Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - 富途牛牛
Tarsus Pharmaceuticals Shares Show Resilience Amid Market Pressure - AD HOC NEWS
Hussman Strategic Advisors Inc. Purchases Shares of 31,500 Tarsus Pharmaceuticals, Inc. $TARS - MarketBeat
Volume Report: How does DMC Global Inc correlate with Nasdaq2025 Major Catalysts & Weekly Top Gainers Trade List - baoquankhu1.vn
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
Universal Beteiligungs und Servicegesellschaft mbH Has $5.44 Million Stake in Tarsus Pharmaceuticals, Inc. $TARS - MarketBeat
Down 16.4% in 4 Weeks, Here's Why You Should You Buy the Dip in Tarsus Pharmaceuticals (TARS) - Finviz
SG Americas Securities LLC Sells 27,833 Shares of Tarsus Pharmaceuticals, Inc. $TARS - Defense World
Why (TARS) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Tarsus Pharmaceuticals, Inc. $TARS Shares Purchased by Jennison Associates LLC - MarketBeat
Portfolio Update: Does Tarsus Pharmaceuticals Inc have declining or rising EPSQuarterly Earnings Report & Long-Term Growth Plans - baoquankhu1.vn
Relative Strength Alert For Tarsus Pharmaceuticals - Nasdaq
Does Tarsus Pharmaceuticals (NASDAQ:TARS) Have A Healthy Balance Sheet? - simplywall.st
Tarsus Pharmaceuticals Inc (TARS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.88%
0.83%
자본화:
|
볼륨(24시간):